Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK The Food and Drug Administration said it has taken steps to strengthen its oversight of medical and pharmaceutical advertising.
“We intend to do all we can under the law to make sure that the information conveyed by prescription drug promotion is as useful as possible,” said FDA commissioner Mark McClellan, in a statement issued on Wednesday. “Our new regulatory guidance provides new direction to sponsors on how to provide higher-quality health information to the public, based on recent evidence on what works and what doesn’t in drug promotion.”
Last
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in